ADiTx Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
27.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.88
|
0.00
|
0.88
|
100.00%
|
|
2022-12-31
|
1.26
|
0.00
|
-1.26
|
-100.00%
|
|
2022-09-30
|
-2.37
|
-5.27
|
-2.90
|
-122.36%
|
|
2022-06-30
|
5.50
|
-6.50
|
-12.00
|
-218.18%
|
|
2022-03-31
|
5.50
|
-7.00
|
-12.50
|
-227.27%
|
|
2021-12-31
|
11.50
|
-15.50
|
-27.00
|
-234.78%
|
|
2021-09-30
|
8.50
|
-28.00
|
-36.50
|
-429.41%
|
|
2021-06-30
|
-2.50
|
-21.00
|
-18.50
|
-740.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-18.77
|
|
2021-12-31
|
-87.50
|
|
2020-12-31
|
-23.12
|
|
2019-12-31
|
-1.70
|
|
2018-12-31
|
-1.37
|
|
2017-12-31
|
-0.52
|